“Big money” Positions

“Big money sentiment for Haemonetics Corp (NYSE:HAE) in Q4 2018 increased to 0.9, according to SEC filings. That’s up 0.24, from 2018Q3’s 0.66. 108 investment professionals opened new or increased positions, while 120 cut down and sold holdings in Haemonetics Corp so the sentiment has improved. Funds own 49.22 million shares, up from 48.30 million shares in 2018Q3. Funds holding Haemonetics Corp in top 10 decreased from 1 to 0 for a decrease of 1. 36 Investors Sold All; 84 Reduced Holdings; 72 increased holdings while 36 investment professionals bought holdings.

Most Haemonetics Corp Shareholders

Picton Mahoney Asset Management owns 163,651 shares in Haemonetics Corp as of Q4 2018. Haemonetics Corp’s shareholder Dorsey Wright & Associates owns 43,003 shares as of Q4 2018. Furthermore, American Capital Management Inc reported 228,000 shares in Haemonetics Corp equivalent to 1.22% of its fund portfolio. The Illinois-based fund Oberweis Asset Management Inc have invested about 0.91% of the active investment manager’s stock portfolio in Haemonetics Corp. The California-based fund Jackson Square Partners Llc holds 1.47 million shares or 0.9% of their fund portfolio.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions.The firm is valued at $4.38 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan.99.87 is the P/E ratio. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

HAE hit $85.89 during the last trading session after $1.32 change.Haemonetics Corporation has 587,133 shares volume, 23.02% up from normal. HAE is uptrending and has moved 23.36% since March 10, 2018. HAE outperformed the S&P500 by 18.99%.

Haemonetics Corporation (NYSE:HAE) is anticipated to report earnings on May, 14., according to Zacks. Analysts predict $0.55 EPS, which is $0.12 up or 27.91 % from 2018’s $0.43 EPS. In case of $0.55 EPS HAE’s profit could be $28.05M. Wall Street predicts -12.70 % negative EPS growth as of May, 14.

Driehaus Ltd Liability holds 19,246 shs or 0.08% of its capital. Price T Rowe Md holds 558,633 shs. Columbus Circle Investors owns 247,320 shs. 2.06M were accumulated by Oregon Pub Employees Retirement Fund. Bessemer Group Incorporated reported 33,900 shs. Alpine Woods Capital Invsts Ltd holds 0.13% or 5,266 shs. Picton Mahoney Asset Management stated it has 1.46% in Haemonetics Corporation (NYSE:HAE). Bank Of America De accumulated 104,034 shs or 0% of the stock. Zeke Capital Limited Co holds 0.11% or 11,610 shs in its capital. Moreover, Smart Portfolios Limited Com has 0.01% invested in Haemonetics Corporation (NYSE:HAE) for 151 shs. Moreover, Moody Financial Bank Trust Division has 0% invested in Haemonetics Corporation (NYSE:HAE) for 80 shs. Ny State Teachers Retirement Sys holds 97,387 shs. Vanguard Gru Incorporated accumulated 0.03% or 5.62M shs. Jpmorgan Chase Co invested in 281,435 shs. Lazard Asset Mgmt Limited Liability holds 3,651 shs.

Haemonetics Corporation had 10 selling transactions and 0 insider buys since September 10, 2018. This’s net activity of $9.23 million. The insider Scanlan Jacqueline sold 4,890 shs worth $548,609. On Thursday, November 8 $1.49 million worth of stock was sold by Burke William P. Mr.. On Wednesday, November 7 the insider KROLL MARK W sold $1.22M. On Friday, December 14 GELBMAN RONALD G also sold $445,974 worth of Haemonetics Corporation (NYSE:HAE). MEELIA RICHARD J sold $843,041 worth of Haemonetics Corporation (NYSE:HAE) on Friday, December 14. On Monday, December 10 $174,227 worth of stock was sold by Goldstein Dan.

For more Haemonetics Corporation (NYSE:HAE) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Haemonetics Q3 2018 Earnings Preview – Seeking Alpha” published on February 04, 2019, “Haemonetics Q3 top line up 6% – Seeking Alpha” on February 05, 2019, “Haemonetics Corp’s (HAE) CEO Christopher Simon on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” with a publish date: August 07, 2018, “Consolidated Research: 2019 Summary Expectations for Corning, Windstream, Deckers Outdoor, Haemonetics, The Descartes Systems Group, and CSG Systems International — Fundamental Analysis, Key Performance Indications – Nasdaq” and the last “Haemonetics Corporation (HAE) CEO Chris Simon on Q3 2019 Results – Earnings Call Transcript – Seeking Alpha” with publication date: February 05, 2019.